These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ainsworth JR; Kraft SP Ophthalmology; 1995 Dec; 102(12):2036-40. PubMed ID: 9098314 [TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin in ophthalmology. Dunlop D; Pittar G; Dunlop C Aust N Z J Ophthalmol; 1988 Feb; 16(1):15-20. PubMed ID: 3401395 [TBL] [Abstract][Full Text] [Related]
24. Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Burns CL; Gammon JA; Gemmill MC Ophthalmology; 1986 Dec; 93(12):1621-7. PubMed ID: 3808621 [TBL] [Abstract][Full Text] [Related]
25. Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm. Wirtschafter JD Ophthalmology; 1991 Mar; 98(3):357-66. PubMed ID: 2023757 [TBL] [Abstract][Full Text] [Related]
26. [Use of botulinum toxin in ophthalmology: current concepts and problems]. Tapiero B; Robert PY; Adenis JP; Riss I J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272 [No Abstract] [Full Text] [Related]
27. [Treatment of dystonic blepharospasm and hemifacial spasm with botulinum toxin: preliminary studies]. Martí MJ; Kulisevsky J; Tolosa E Med Clin (Barc); 1987 Sep; 89(8):321-3. PubMed ID: 3320608 [No Abstract] [Full Text] [Related]
28. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Dutton JJ Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Singer M Ophthalmology; 1996 Mar; 103(3):348. PubMed ID: 8600402 [No Abstract] [Full Text] [Related]
31. Botulinum toxin for the treatment of essential blepharospasm. Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585 [TBL] [Abstract][Full Text] [Related]
32. Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening. Defazio G; Lepore V; Lamberti P; Livrea P; Ferrari E Ital J Neurol Sci; 1990 Jun; 11(3):275-80. PubMed ID: 2387698 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients]. Elbaz D Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486 [TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of involuntary facial spasms using botulinum toxin. Ruusuvaara P; Setälä K Acta Ophthalmol (Copenh); 1990 Jun; 68(3):331-8. PubMed ID: 2392912 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A in blepharospasm and hemifacial spasm. Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509 [TBL] [Abstract][Full Text] [Related]
36. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Taylor JD; Kraft SP; Kazdan MS; Flanders M; Cadera W; Orton RB Can J Ophthalmol; 1991 Apr; 26(3):133-8. PubMed ID: 2054723 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin in the management of blepharospasm. Dutton JJ; Buckley EG Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621 [TBL] [Abstract][Full Text] [Related]
38. Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases. Maurri S; Brogelli S; Alfieri G; Barontini F Ital J Neurol Sci; 1988 Aug; 9(4):337-44. PubMed ID: 3220708 [TBL] [Abstract][Full Text] [Related]
39. The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment. Seiff SR; Shorr N Am J Ophthalmol; 1988 Dec; 106(6):764-6. PubMed ID: 3195671 [No Abstract] [Full Text] [Related]
40. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Eleopra R; Tugnoli V; Caniatti L; De Grandis D Neurology; 1996 Apr; 46(4):1158-60. PubMed ID: 8780112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]